Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05546879
Title Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable Hepatocellular Carcinoma (Liver-NET1)
Acronym Liver-NET1
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University Hospital, Grenoble
Age Groups: adult | senior
Covered Countries FRA

No variant requirements are available.